Latest Breaking News On - Reverse phase protein array - Page 1 : vimarsana.com

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 Theralink Technologies , a precision oncology company with an exclusively licensed commercial RPPA technology platform, is excited to.

United statesSan franciscoTrevor mccartneyEmanuelf petricoinGlobenewswire incUniversity professorUniversity of californiaGeorge mason universityTheralink technologies incSecurities exchangeMason science school of systems biologyExchange commissionMason universityCell reports medicineResponse predictive signatureTriple negative breast cancer

Theralink® and IMAC Holdings announce receipt and response

Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision.

United statesTrevor mccartneyExchange commissionTheralink technologies incHoldings incSecurities exchangeChief executive officerFaith zaslavskyTheralink technologiesReverse phase protein arraySecurities actSecurities exchange actMerger agreementQuarterly reportsCurrent reportsAnnual reports

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute s Molecular Tumor Board

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute s Molecular Tumor Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTrevor mccartneySecurities exchangeExchange commissionHoldings incGastrointestinal cancer program at inovaInova schar cancer instituteTheralink technologies incMolecular tumor boardInova schar molecular tumorInova schar cancerFaith zaslavskyChief executive officerTimothy cannonSheridan directorInova molecular tumor board

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute s Molecular Tumor Board -November 03, 2023 at 09:16 am EDT

Golden, Colorado, Nov. 03, 2023 Theralink Technologies, Inc. , a precision oncology company with its exclusive commercial RPPA technology that can help predict which FDA-approved drug is.

United statesTrevor mccartneyExchange commissionInova schar cancer instituteGastrointestinal cancer programSecurities exchangeHoldings incTheralink technologies incGlobenewswire incSchar cancer instituteMolecular tumor boardInova schar molecular tumorSchar cancerChief executive officerInova molecular tumor boardReverse phase protein array

IMAC Holdings Announces $4 3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

Franklin, Tennessee, July 26, 2023 IMAC Holdings, Inc. , a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced.

United statesTheralink technologies incTechnologies incHoldings incGlobenewswire incJoseph gunnar coExchange commissionTheralink technologiesPreferred stockSecurities actReverse phase protein array